March 14, 2018 / 12:04 PM / a year ago

BUZZ-Valeant Pharma: Health Canada approves drug for plaque psoriasis

** Canadian drugmaker’s U.S.-listed shares up ~2 pct at $16.40 in premarket trade

** Says Health Canada approved its drug Siliq to treat adults with moderate-to-severe plaque psoriasis

** VRX expects to start marketing Siliq in Canada in second half of 2018

** Last year, Siliq was approved by the U.S. regulators with a boxed warning to treat moderate-to-severe plaque psoriasis

** Psoriasis is an autoimmune disorder that occurs more commonly in patients with a family history of the disease; plaque psoriasis, in which patients develop thick, red skin with flaky, silver-white scales, is the most common form of the disease

** Up to Tuesday’s close, stock had fallen ~23 pct this year (Reporting by Akankshita Mukhopadhyay in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below